Vetsys Pharmaceutical
Vetsys Pharmaceutical
Explore our high-performance veterinary formulations and raw active compounds designed to maximize livestock resistance, support metabolic pathways, and elevate general systemic immunity.
In the modern macro-agricultural landscape, the shift from post-infection therapeutics to preventive immunity frameworks is accelerating rapidly. Global commercial integrators, large-scale livestock operations, and feed manufacturers face mounting pressures: strict antibiotic-free (ABF) mandates, emerging systemic pathogens, and the critical need to optimize feed conversion ratios (FCR) under intense market conditions. Consequently, bulk sourcing of high-efficacy veterinary immune boosters is no longer optional; it is a foundational pillar of sustainable herd and flock management.
Industrial buyers require strategic partnerships with manufacturers capable of delivering batch-to-batch consistency. Raw immunomodulators, phytogenic compounds, and bioactive extracts must not only survive feed processing thermal profiles (such as conditioning and extrusion) but also remain highly bioavailable within the digestive tract of target species. Our GMP-certified manufacturing processes ensure that molecular integrity remains intact, offering maximum biological value to feed mills, premix producers, and veterinary suppliers globally.
As a prominent Chinese pharmaceutical manufacturer, we satisfy these requirements by implementing rigorous control points over active pharmaceutical ingredients (APIs) and plant-based fractions. Whether sourcing biological emulsifiers like Gum Arabic to enhance fat-soluble immunomodulator absorption, or utilizing purified Astragalus Polysaccharides to upregulate cytokine pathways, we provide global markets with verified molecular potency.
Thermal Stability: Active compounds withstand high pelleting and extrusion temperatures without denaturing.
Regulatory Alignment: Comprehensive documentation support matching European, African, and FDA import expectations.
Synergistic Formulation: Custom premixing options incorporating immune boosters directly into established antibiotic alternatives.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, represents the peak of quality in the animal pharmaceutical domain. Backed by a registered capital of 30 million RMB, Vetsys operates a state-of-the-art manufacturing campus designed to meet stringent Good Manufacturing Practices (GMP). Our modern facilities include specialized production lines for powder formulations, premixes, sterile injections, oral solutions, tablets, granulations, herbal drug extractions, and robust biosecurity disinfectants.
Innovation is built into our corporate identity. Vetsys runs an independent research institute featuring five specialized laboratories staffed by world-class veterinary pharmacologists and bioprocess engineers. This powerhouse R&D structure enables us to react immediately to macro industry shifts, shifting quickly from molecular isolation to commercialized, feed-stable products. By 2015, our commitment to technical superiority fueled annual domestic sales past the USD 20 million mark, establishing Vetsys as a primary benchmark supplier in China’s agricultural economy.
At Vetsys, quality management underpins every lifecycle phase of production. We source high-purity APIs, enforce strict internal HPLC/GC-MS testing on raw botanical materials like raw Astragalus root slices, and run continuous inline monitoring. From mold preparation to final logistics sealing, our operations are designed to eliminate contamination risk and secure long-term product potency.
Our physical infrastructure is built to support both veterinary formulation blending and packaging device manufacturing. Below is an overview of the key processing and production steps executed within our GMP-regulated facility walls to maintain operational superiority.
The next decade of animal production will demand deep molecular specificity. Simple growth promoters are being replaced by bio-rational immune modulators that target specific cellular pathways. Our scientific roadmap is built on two primary fronts: Phytogenic Polysaccharide Engineering and High-Efficiency API Synthesis.
By deploying state-of-the-art enzymatic extraction protocols, we optimize the molecular weight distribution of Astragalus Polysaccharides. This structural refinement ensures high affinity binding to macrophage receptors, driving up-regulation of IL-2 and interferon-gamma, establishing stronger mucosal immunity against enteric and respiratory pathogens.
We integrate advanced carriers (such as Fulvic Acid soluble matrices and Gum Arabic emulsified systems) to achieve sustained-release kinetics. This prevents the premature degradation of active therapeutic compounds like Oxytetracycline and Tiamulin, maximizing their efficacy at lower doses.
Navigating the regulatory systems of international commerce requires extensive paperwork and verification. At Vetsys, our dedicated regulatory affairs department works continuously with international standards boards. We provide comprehensive dossiers including certificate of analysis (COA), safety data sheets (SDS), product stability test data, and GMP verification files to facilitate fast customs clearance across European, African, Southeast Asian, and American markets.
Simultaneously, we recognize our environmental obligations. Vetsys actively implements green production methods, incorporating energy-saving waste treatment equipment and low-carbon drying chambers (as shown in our drying process section). Our focus on sustainability ensures that our manufacturing processes are as safe and clean as the final products themselves, helping global buyers achieve their ESG targets without compromising on quality.
Expand your operational throughput with our highly regarded feed supplements, technical polymers, and processing machinery.
